Amneal gets FDA approval for memantine/donepezil extended-release capsules
Amneal Pharmaceuticals (AMRX) announced that the FDA has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which ...
Pharm Exec1d
FDA Approves Two Generics from Amneal Pharmaceuticals for Alzheimer and Oncology, with Tentative Approval for Gastrointestinal Disease
As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...
Amneal gains FDA approval for dementia and oncology drugs
BRIDGEWATER, N.J. - Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX), a pharmaceutical company with a market capitalization of ...
Medscape12y
Donepezil Effective in Dementia With Lewy Bodies
Due to the well-known cholinergic deficit in this disease, Mori and colleagues (2012) explored the use of a cholinesterase inhibitor, donepezil, for the treatment of DLB. The authors enrolled ...